Amplification of Kinin-Induced Hypotension by Nitric Oxide Synthesis in Spontaneously Hypertensive Rats

Hypertension

Volumn 29, Issue 1, 1997, Pages 53-57

  Bjornstad Ostensen, Anniken ^a   Holte, Hege Ruge ^a   Berg, Torill ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BRADYKININ; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PHENTOLAMINE;

ADRENERGIC SYSTEM; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; HYPOTENSION; INBRED STRAIN; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR ENDOTHELIUM;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BLOOD PRESSURE; BRADYKININ; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HYPERTENSION; HYPOTENSION; INJECTIONS, INTRAVENOUS; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHENTOLAMINE; RATS; RATS, INBRED SHR; RATS, INBRED WKY;

EID: 0031041164     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.29.1.53     Document Type: Article

References (23)

1. Kiowski W, Linder L, Kleinbloesem C, van Brummel P, Buhler FR. Blood pressure control by the renin-angiotensin system in normotensive subjects: assessment by angiotensin converting enzyme and renin inhibition. Circulation. 1992;85:1-8.
2. Pellacani A, Brunner HR, Nussberger J. Antagonizing and measurement: approaches to understanding of hemodynamic effects of kinins. J Cardiovasc Pharmacol. 1992;20(suppl 9):28-34.
3. Benetos A, Gavras H, Stewart JM, Vavrek RJ, Hatinoglou S, Gavras I. Vasodepressor role of endogenous bradykinin assessed by a bradykinin antagonist. Hypertension. 1986;8:971-974.
4. Carbonell LF, Carretero OA, Stewart JM, Scicli AG. Effect of a kinin antagonist on the acute antihypertensive activity of enalaprilat in severe hypertension. Hypertension. 1988;11:239-243.
5. Cachofeiro V, Sakakibara T, Nasjletti A. Kinins, nitric oxide, and the hypertensive effect of captopril and ramiprilat in hypertension. Hypertension. 1992;19:137-145.
6. O'Shaughnessy KM, Newman CM, Warren JB. Inhibition in the rat of nitric oxide synthesis in vivo does not attenuate the hypotensive action of acetylcholine, ATP or bradykinin. Exp Physiol. 1992;77:285-292.
7. Kelm M, Schrader J. Nitric oxide release from the isolated guinea pig heart. Eur J Pharmacol. 1988;155:317-321.
8. Rees DD, Palmer RMJ, Schulz R, Hodson HF, Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol. 1990;101:746-752.
9. Bjornstad-Ostensen A, Berg T. The role of nitric oxide, adrenergic activation and kinin-degradation in blood pressure homeostasis following an acute kinin-induced hypotension. Br J Pharmacol. 1994;113:1567-1573.
10. Cherry PD, Furchgott RF, Zawadzki JV, Jothianandan D. Role of endothelial cells in relaxation of isolated arteries by bradykinin. Proc Natl Acad Sci U S A. 1982;79:2106-2110.
11. Dzau VJ. Multiple pathways of angiotensin production in the blood vessel wall: evidence, possibilities and hypotheses. J Hypertens. 1989;7:933-936.
12. Burnstock G. Local mechanisms of blood flow control by perivascular nerves and endothelium. J Hypertens. 1990;8(suppl 7):S95-S106.
13. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988;333:664-666.
14. Bogle RG, Coade SB, Moncada S, Pearson JD, Mann GE. Bradykinin and ATP stimulate L-arginine uptake and nitric oxide release in vascular endothelial cells. Biochem Biophys Res Commun. 1991;180:926-932.
15. Wiemer G, Scholkens BA, Becker RHA, Busse R. Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension. 1991;18:558-563.
16. Whittle BJR, Lopez-Belmonte J, Rees DD. Modulation of the vasodepressor actions of acetylcholine, bradykinin, substance P and endothelin in rat by a specific inhibitor of nitric oxide formation. Br J Pharmacol. 1989;98:646-652.
17. Mombouli JV, Vanhoutte PM. Endothelium-derived hyperpolarizing factor(s) and the potentiation of kinins by converting enzyme inhibitors. Am J Hypertens. 1995;8:19S-27S.
18. O'Kane KP, Webb DJ, Collier JG, Vallance PJ. Local L-NG-monomethyl-arginine attenuates the vasodilator action of bradykinin in the human forearm. Br J Clin Pharmacol. 1994;38:311-315.
19. Yoshiyama M, Miura K, Nishikimi T, Teragaki M, Todi I, Akioka K, Takeuchi K, Takeda T. Role of nitric oxide in the vasodilatory response to acetylcholine and bradykinin in perfused hearts. Jpn Circ J. 1993;57:1159-1163.
20. White DG, Drew GM, Gurden JM, Penny DM, Roach AG, Watts IS. The effect of NG-nitro-L-arginine methyl ester upon basal blood flow and endothelium-dependent vasodilatation in the dog hindlimb. Br J Pharmacol. 1993;108:763-768.
21. Holte HR, Bjornstad-Ostensen A, Berg T. The role of endogenous bradykinin in blood pressure homeostasis in spontaneously hypertensive rats. Br J Pharmacol. 1996;118:1925-1930.
22. Madeddu P, Parpaglia PP, Demontis MP, Varoni MV, Fattaccio MC, Tonolo G, Troffa C, Glorioso N. Bradykinin B2-receptor blockade facilitates deoxycorticosterone-salt hypertension. Hypertension. 1993;21:980-984.
23. Fleming I, Dambacher T, Busse R. Endothelium-derived kinins account for the immediate response of endothelial cells to bacterial lipopolysaccharide. J Cardiovasc Pharmacol. 1992;20(suppl 12):S135-S138.